Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03067129 |
|---|---|
| Brief Title: | A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection (DORA) |
| First Submitted : | February 24, 2017 |
| First Submitted that Met QC Criteria : | February 24, 2017 |
| First Posted : | March 1, 2017 |
| Results First Submitted : | May 14, 2021 |
| Results First Posted with QC Comments : | June 10, 2021 |
| Results First Submitted that Met QC Criteria : | June 21, 2021 |
| Results First Posted : | July 13, 2021 |
| Last Update Submitted that Met QC Criteria : | September 19, 2022 |
| Last Update Posted : | September 30, 2022 |